Health Condition 1: M049- Autoinflammatory syndrome, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: patients on HCQ treatment for any rheumatological or dermatological disorder with refractive error less than or equal to +/- 4D and cylinder of less than or equal to -3D with an intraocular pressure measurement of less than 21 mmHg
Exclusion criteria
Exclusion criteria: patients diagnosed to have HCQ retinopathy or having systemic diseases like Hypertension, kidney disorder or diabetes mellitus . patients having retinal pigment epithelial abnormalities , or media opacities, glaucoma, preexisting retinal pathology or paracentral scotomas on visual field testing and patients having colour vision defects
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study the thickness of Ganglion cell complex at the macula in patients taking HCQ Timepoint: at baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation of GCC Thickness with vessel density changes in SCP & DCP layer in OCTA. To study correlation of GCC thickness with cumulative dose of HCQ. Timepoint: at baseline | — |
Countries
India
Contacts
Sankara Eye Hospital, bengaluru